13F Holdings
中文EN

YCBD cbdMD, Inc.

Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1644903 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.0%
TTM net income YoY-90.8%
TTM EPS YoY—
Revenue 3-yr CAGR-7.3%
Net income 3-yr CAGR—

Margins

Gross margin57.7%
Operating margin-13.9%
Net margin-13.8%
FCF margin-11.5%
EBITDA margin-12.8%

Returns

ROE-40.3%
ROA-25.1%
ROIC (approx.)-41.2%
Asset turnover1.82x

Leverage & solvency

Liabilities / assets37.5%
Debt / equity0.00x
Current ratio2.50x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.77x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue$19.19M$19.48M$24.16M$35.40M$44.48M
Cost of revenue$7.22M$7.49M$9.18M$13.07M$14.50M
Gross profit$11.97M$12.00M$14.98M$22.34M$29.99M
Operating income-$2.16M-$3.32M-$22.49M-$78.27M-$19.62M
Pretax income-$2.04M-$3.70M-$22.94M-$70.08M-$24.29M
Income tax$0$0$0$0-$895,000
Net income-$2.04M-$3.70M-$22.94M-$70.08M-$23.39M
EBITDA-$1.80M-$2.86M-$22.08M-$77.32M-$18.60M
EPS (basic)-1.09-14.29-13.32-55.80-0.47
EPS (diluted)-1.09-14.29-13.32-55.80-0.47
Weighted avg. shares (diluted)4.02M539,0692.02M1.33M54.94M
Banking
Net interest income$34,308-$29,507$63,702$16,246-$28,930
Balance sheet
Cash & equivalents$2.26M$2.45M$1.80M$6.72M$26.41M
Short-term investments———$0$33,351
Receivables$786,449$621,678$1.22M$273,451—
Inventory$2.95M$2.52M$4.24M$4.77M$5.57M
Current assets$6.55M$6.39M$8.07M$16.01M$36.50M
PP&E, net$277,377$454,268$716,579$823,310$2.56M
Goodwill$0—$0$0$56.67M
Intangibles$2.12M$2.89M$3.22M$17.83M$23.00M
Total assets$10.42M$10.58M$16.20M$40.79M$124.88M
Current liabilities$3.19M$8.62M$4.67M$5.29M$6.92M
Long-term debt——$9$125,491$108,985
Total debt——$9$125,491$108,985
Total liabilities$3.19M$8.62M$7.16M$9.37M$21.74M
Shareholders' equity$7.23M$1.96M$9.03M$31.42M$103.14M
Net debt——-$1.80M-$6.59M-$26.30M
Shares outstanding8.92M492,3832.96M1.35M57.78M
Cash flow statement
Operating cash flow-$1.45M-$352,792-$4.30M-$14.97M-$14.09M
Capital expenditure$184,172$190,015$297,549$688,680$342,013
Free cash flow-$1.64M-$542,807-$4.60M-$15.66M-$14.44M
Investing cash flow-$184,172-$290,015$702,451-$688,680-$2.55M
Financing cash flow$1.45M$1.30M-$1.32M-$4.04M$28.23M
Depreciation & amortization$361,063$452,326$404,280$948,962$1.02M
Stock-based compensation————$1.30M
Dividends paid————$2.55M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.